Lorigerlimab | MedChemExpress (MCE)
Lorigerlimab (MGD019) is a bispecific IgG4 dual-affinity re-targeting antibody (DART). Lorigerlimab can block PD-1 and CTLA-4, and improves T-cell responses. Lorigerlimab can be used for research of metastatic castration-resistant prostate cancer (mCRPC)[1][2][3].
| Trivial name | Lorigerlimab |
| Catalog Number | HY-P99714 |
| Alternative Name(s) | MGD019 |
| Research Area | Cancer |
| CAS# | 2416595-46-3 |
| Purity | ≥98.00% |
| SMILES | [Lorigerlimab] |
| Size | 1 mg |
| Supplier Page | https://www.medchemexpress.com/lorigerlimab.html |